questionsmedicales.fr
Bactéries
Proteobacteria
Betaproteobacteria
Burkholderiales
Burkholderiaceae
Burkholderiaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections bactériennes
Diagnostic microbiologique
Polymerase Chain Reaction
Séquençage génétique
Symptômes
Infections bactériennes
Tests sérologiques
Infections bactériennes
Antibiogramme
Sensibilité aux antibiotiques
Symptômes
5
Symptômes
Infections bactériennes
Infections pulmonaires
Immunodépression
Infections cutanées
Traumatismes
Symptômes neurologiques
Infections bactériennes
Variabilité des symptômes
Infections bactériennes
Prévention
5
Prévention des infections
Hygiène
Vaccins
Prévention des infections
Surveillance médicale
Immunodépression
Hygiène hospitalière
Infections nosocomiales
Équipements de protection
Prévention des infections
Traitements
5
Antibiotiques
Infections bactériennes
Résistance aux antibiotiques
Infections bactériennes
Thérapies ciblées
Infections bactériennes
Prévention des infections
Immunodépression
Durée du traitement
Infections bactériennes
Complications
5
Complications
Infections bactériennes
Infections mortelles
Immunodépression
Complications neurologiques
Infections bactériennes
Hospitalisation
Infections bactériennes
Séquelles
Infections bactériennes
Facteurs de risque
5
Facteurs de risque
Immunodépression
Cysticfibrose
Infections bactériennes
Personnes âgées
Immunodépression
Travailleurs de la santé
Infections nosocomiales
Voyages
Infections bactériennes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Burkholderiaceae : Questions médicales les plus fréquentes",
"headline": "Burkholderiaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Burkholderiaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-16",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Burkholderiales",
"url": "https://questionsmedicales.fr/mesh/D000073556",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiales",
"code": {
"@type": "MedicalCode",
"code": "D000073556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia",
"alternateName": "Burkholderia",
"url": "https://questionsmedicales.fr/mesh/D019117",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia",
"code": {
"@type": "MedicalCode",
"code": "D019117",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia complex",
"alternateName": "Burkholderia cepacia complex",
"url": "https://questionsmedicales.fr/mesh/D042602",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia complex",
"code": {
"@type": "MedicalCode",
"code": "D042602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia gladioli",
"alternateName": "Burkholderia gladioli",
"url": "https://questionsmedicales.fr/mesh/D042725",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia gladioli",
"code": {
"@type": "MedicalCode",
"code": "D042725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.355"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia mallei",
"alternateName": "Burkholderia mallei",
"url": "https://questionsmedicales.fr/mesh/D042726",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia mallei",
"code": {
"@type": "MedicalCode",
"code": "D042726",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.477"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia pseudomallei",
"alternateName": "Burkholderia pseudomallei",
"url": "https://questionsmedicales.fr/mesh/D016957",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia pseudomallei",
"code": {
"@type": "MedicalCode",
"code": "D016957",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cupriavidus",
"alternateName": "Cupriavidus",
"url": "https://questionsmedicales.fr/mesh/D049921",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus",
"code": {
"@type": "MedicalCode",
"code": "D049921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cupriavidus necator",
"alternateName": "Cupriavidus necator",
"url": "https://questionsmedicales.fr/mesh/D020118",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus necator",
"code": {
"@type": "MedicalCode",
"code": "D020118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia",
"alternateName": "Ralstonia",
"url": "https://questionsmedicales.fr/mesh/D043367",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia",
"code": {
"@type": "MedicalCode",
"code": "D043367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ralstonia pickettii",
"alternateName": "Ralstonia pickettii",
"url": "https://questionsmedicales.fr/mesh/D049920",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia pickettii",
"code": {
"@type": "MedicalCode",
"code": "D049920",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia solanacearum",
"alternateName": "Ralstonia solanacearum",
"url": "https://questionsmedicales.fr/mesh/D043368",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia solanacearum",
"code": {
"@type": "MedicalCode",
"code": "D043368",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae",
"alternateName": "Burkholderiaceae",
"code": {
"@type": "MedicalCode",
"code": "D042521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yusuke Takashima",
"url": "https://questionsmedicales.fr/author/Yusuke%20Takashima",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Yousuke Degawa",
"url": "https://questionsmedicales.fr/author/Yousuke%20Degawa",
"affiliation": {
"@type": "Organization",
"name": "Sugadaira Research Station Mountain Science Center, University of Tsukuba."
}
},
{
"@type": "Person",
"name": "Tomoyasu Nishizawa",
"url": "https://questionsmedicales.fr/author/Tomoyasu%20Nishizawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Hiroyuki Ohta",
"url": "https://questionsmedicales.fr/author/Hiroyuki%20Ohta",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Kazuhiko Narisawa",
"url": "https://questionsmedicales.fr/author/Kazuhiko%20Narisawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36546488",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/phcfm.v14i1.3736"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/35964881",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jvir.2022.08.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate organogenesis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35726824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/dev.200394"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Urethral Length as a Predictor for Surgery in Benign Prostatic Hyperplasia.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36974872",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33314/jnhrc.v20i3.4613"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Betaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020562"
},
{
"@type": "ListItem",
"position": 5,
"name": "Burkholderiales",
"item": "https://questionsmedicales.fr/mesh/D000073556"
},
{
"@type": "ListItem",
"position": 6,
"name": "Burkholderiaceae",
"item": "https://questionsmedicales.fr/mesh/D042521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Burkholderiaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Burkholderiaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Burkholderiaceae",
"description": "Comment diagnostiquer une infection par Burkholderiaceae ?\nQuels tests sont utilisés pour identifier Burkholderia ?\nLes symptômes aident-ils au diagnostic ?\nLes tests sérologiques sont-ils utiles ?\nQuelle est l'importance de l'antibiogramme ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Prostate#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Burkholderiaceae",
"description": "Quels sont les symptômes d'une infection par Burkholderia ?\nLes infections pulmonaires sont-elles fréquentes ?\nBurkholderia peut-elle causer des infections cutanées ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon le type de Burkholderia ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Prostate#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Burkholderiaceae",
"description": "Comment prévenir les infections par Burkholderia ?\nLes vaccinations sont-elles efficaces ?\nLes personnes à risque doivent-elles être surveillées ?\nLes mesures d'hygiène hospitalière sont-elles importantes ?\nLes équipements de protection individuelle sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Prostate#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Burkholderiaceae",
"description": "Quel est le traitement standard pour les infections par Burkholderia ?\nLes infections sont-elles résistantes aux antibiotiques ?\nDes traitements alternatifs existent-ils ?\nLe traitement préventif est-il possible ?\nQuelle est la durée du traitement antibiotique ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Prostate#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Burkholderiaceae",
"description": "Quelles sont les complications possibles d'une infection par Burkholderia ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il des complications neurologiques ?\nLes infections peuvent-elles entraîner des hospitalisations prolongées ?\nQuelles sont les séquelles possibles après une infection ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Prostate#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Burkholderiaceae",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes patients atteints de cysticfibrose sont-ils à risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes travailleurs de la santé sont-ils exposés ?\nLes voyages dans certaines régions augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Prostate#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Burkholderiaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Burkholderia ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests PCR et des séquençages génétiques sont souvent utilisés pour l'identification."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter vers une infection, mais ne suffisent pas."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques sont-ils utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques peuvent aider, mais ne sont pas toujours fiables pour Burkholderia."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'antibiogramme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'antibiogramme est crucial pour déterminer la sensibilité aux antibiotiques des souches isolées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection par Burkholderia ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, douleurs thoraciques et parfois des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Les infections pulmonaires sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections pulmonaires, notamment chez les patients immunodéprimés, sont courantes."
}
},
{
"@type": "Question",
"name": "Burkholderia peut-elle causer des infections cutanées ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections cutanées peuvent survenir, surtout après des blessures ou des brûlures."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques peuvent apparaître, mais ils sont moins fréquents et souvent graves."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de Burkholderia ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon l'espèce de Burkholderia et l'état du patient."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Burkholderia ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une bonne hygiène, des soins appropriés des plaies et l'évitement des contacts à risque."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques contre les infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ou avec des maladies chroniques doivent être surveillées de près."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène hospitalière sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures strictes d'hygiène hospitalière sont essentielles pour prévenir les infections nosocomiales."
}
},
{
"@type": "Question",
"name": "Les équipements de protection individuelle sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation d'équipements de protection individuelle est recommandée dans les milieux à risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour les infections par Burkholderia ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques comme la céftazidime ou le meropenem."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles résistantes aux antibiotiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines souches de Burkholderia montrent une résistance significative aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs peuvent inclure des combinaisons d'antibiotiques ou des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il possible ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement préventif peut être envisagé pour les patients à risque élevé d'infection."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement antibiotique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais elle est généralement de 2 à 4 semaines selon la gravité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection par Burkholderia ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des septicémies, des infections pulmonaires graves et des abcès."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections par Burkholderia peuvent être mortelles, surtout chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, bien que rares, peuvent survenir, entraînant des séquelles."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles entraîner des hospitalisations prolongées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections graves par Burkholderia peuvent nécessiter des hospitalisations prolongées."
}
},
{
"@type": "Question",
"name": "Quelles sont les séquelles possibles après une infection ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les séquelles peuvent inclure des problèmes respiratoires chroniques ou des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, les maladies chroniques et les traumatismes."
}
},
{
"@type": "Question",
"name": "Les patients atteints de cysticfibrose sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients atteints de cysticfibrose sont particulièrement vulnérables aux infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru d'infections en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils exposés ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé peuvent être exposés à des souches résistantes dans les hôpitaux."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où Burkholderia est endémique peut augmenter le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
2 publications dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
1 publication dans cette catégorie
Affiliations :
Publications dans "Burkholderiaceae" :
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
To compare the cost effectiveness of prostatic artery embolization (PAE) with that of transurethral resection of the prostate (TURP) for the treatment of medically refractory benign prostatic hyperpla...
A cost-effectiveness analysis with Markov modeling was performed, comparing the clinical course after PAE with that after TURP for 3 years. Probabilities were obtained from the available literature, a...
Base case calculation showed comparable outcomes (PAE, 2.845 QALY; TURP, 2.854 QALY), with a cost difference of $3,104 (PAE, $2,934; TURP, $6,038). The incremental cost-effectiveness ratio was $360,24...
PAE is a cost-effective strategy to treat medically refractory BPH, resulting in comparable health benefits at a lower cost than that of TURP even when accounting for extreme alterations in adverse ev...
Prostate organogenesis begins during embryonic development and continues through puberty when the prostate becomes an important exocrine gland of the male reproductive system. The specification and gr...
Benign prostatic hyperplasia is associated with structural and morphological changes including elongation of prostatic urethral length. The aim of our study was to assess whether prostatic urethral le...
This prospective observational study was conducted over a 12-months duration. All the patients who presented with lower urinary tract symptoms secondary to benign prostatic hyperplasia were evaluated ...
A total of 153 patients were included in the study. Eighty-three (54.2%) patients underwent surgery during the study period. Prostate volume, intravesical prostatic protrusion, post-void residual volu...
BPH patients with longer PUL may require surgical management. PUL measured by TRUS may be a predicting factor for the need of surgery in BPH Keywords: Benign prostatic hyperplasia; lower urinary tract...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...
